AKTIS ONCOLOGY ENTERS INTO STRATEGIC COLLABORATION …

May 21, 2024 · Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, …

CouponFollow Extension

$60
OFF

AKTIS ONCOLOGY ENTERS INTO STRATEGIC COLLABORATION …

4 weeks from now

May 21, 2024 · Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, …

aktisoncology.com

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Eli Lilly has entered into a strategic multi-target discovery collaboration agreement with Aktis Oncology in a deal worth more than $1bn to develop novel anticancer …

pmlive.com

$1
OFF

Eli Lilly And Aktis Enter $1bn Partnership To Develop Anticancer ...

4 weeks from now

May 23, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$1
OFF

AKTIS ONCOLOGY ENTERS INTO STRATEGIC …

4 weeks from now

the collaboration in addition to an equity investment in Aktis by Lilly. In addition, Aktis will be eligible to receive up to an additional $1.1 billion in potential preclinical, clinical, regulatory and …

pappas-capital.com

$1
OFF

Lilly Inks Potential $1.1B Radiopharma Deal With Aktis Oncology

4 weeks from now

May 21, 2024 · Eli Lilly is paying $60 million upfront to Aktis Oncology to discover and develop novel tumor-targeting radiopharmaceuticals, as radiopharma dealmaking continues to heat up …

biospace.com

$60
OFF

Lilly Partners With Aktis, Deepening Radiopharma Investment

4 weeks from now

May 21, 2024 · Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million …

biopharmadive.com

$60
OFF

Aktis Oncology And Lilly To Discover And Develop Novel Anticancer ...

4 weeks from now

May 28, 2024 · Under the terms of the agreement, Aktis will receive a $60 million upfront cash payment for the collaboration in addition to an equity investment in Aktis by Lilly. In addition, …

pbiforum.net

$1
OFF

Aktis To Collaborate With Eli Lilly On Cancer Therapies

4 weeks from now

May 21, 2024 · Aktis Oncology said on Tuesday it will collaborate with Eli Lilly to develop cancer therapies, making it eligible for milestone payments of up to $1.1 billion and royalties on sales.

reuters.com

$1
OFF

Lilly Collaborates With Aktis To Strengthen Radiopharma Portfolio

4 weeks from now

May 21, 2024 · Eli Lilly previously inked a $1.4bn deal to acquire radiopharmaceutical company POINT Biopharma in October 2023. Credit: Michael Vi via Shutterstock. ... Lilly will give Aktis …

pharmaceutical-technology.com

$60
OFF

Eli Lilly And Co., Partners With Boston Biotech Company To Develop ...

4 weeks from now

May 21, 2024 · As a part of the deal between the two companies, Aktis will receive $60 million and another $1.1 billion in royalties for reaching certain milestones in development of new …

indystar.com

$60
OFF

Lilly, Aktis Sign Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

May 27, 2024 · Eli Lilly and Company has tapped Boston biotechnology firm Aktis Oncology to make new radiopharmaceuticals for solid tumors. Lilly will pay Aktis $60 million up front and up …

acs.org

$1.16
OFF

Lilly Inks Potential $1.16B Deal With Radiopharma Startup

4 weeks from now

May 21, 2024 · Eli Lilly has partnered with Boston-based biotech Aktis Oncology to develop innovative anticancer radiopharmaceuticals using Aktis’ proprietary miniprotein discovery …

pharmamanufacturing.com

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Aktis took the other side of the deal, agreeing to use its platform to generate anticancer candidates against targets chosen by Lilly. The agreement is worth $60 million …

fiercebiotech.com

FAQs about AKTIS ONCOLOGY ENTERS INTO STRATEGIC COLLABORATION … Coupon?

What is aktis oncology doing with Eli Lilly?

Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology’s novel miniprotein technology platform. ...

Will Aktis partner with Lilly?

Aktis Oncology has entered into a strategic collaboration with Lilly to discover and develop targeted radiopharmaceuticals. Under the terms of the agreement, Aktis will partner with Lilly and receive a $60 million upfront cash payment, along with an equity investment in Aktis by Lilly. ...

What rights does Lilly receive from Aktis?

In exchange, Lilly will receive worldwide rights to develop radiopharmaceutical therapeutic and diagnostic products discovered by Aktis on a defined set of targets selected by Lilly. ...

Will Lilly acquire aktis pharmaceuticals?

Under the terms of the agreement, Lilly will gain worldwide rights to develop targets for radiopharmaceuticals discovered by Aktis. However, the deal does not include Aktis’ current pipeline, which consists of seven programmes. ...

How much money will aktis get from Lilly?

As a part of the deal between the two companies, Aktis will receive $60 million and another $1.1 billion in royalties for reaching certain milestones in development of new drugs. Lilly will get the rights to develop treatments discovered by Aktis. ...

Who is aktis oncology?

Related article: Eli Lilly Expands Oncology Portfolio with $1.4 Billion Acquisition of POINT Biopharma Aktis Oncology is at the forefront of developing targeted alpha radiopharmaceuticals designed to treat a wide range of solid tumors. ...